The Scientific Advisory Board is a focused group of external thought leaders that provide independent opinions and recommendations about Caris Life Sciences® initiatives and services. The Caris advisory board includes experts in contemporary cancer research, drug and diagnostic development, clinical trial design, regulatory issues and reimbursement policy, as well as clinical oncologists from both the community and academic medical center settings.

Vice Chairman

Former Vice President and Head of Precision Medicine at Bristol-Myers Squibb

Co-Director, Complex Adaptive Systems Initiative, Arizona State University

Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center

Professor of Medicine, Harvard Medical School

Professor, Department of Neurosurgery, The University of Texas MD Anderson Cancer Center

Deputy Director, University of Cincinnati Cancer Institute and The Barrett Cancer Center

Professor of Microbiology and Immunology, Stanford University

Vice President and Executive Dean for West Virginia University Health Sciences

Professor of Medicine and Oncology, Georgetown University

Leader, National RAS Initiative

Neurologist and Management Consultant, Johns Hopkins School of Medicine

President and Chief Executive Officer, ESSA Pharma, Inc.

Professor, Computational Biology and Bioinformatics, Harvard School of Public Health

Chair of the Robert J. Tomsich Pathology & Laboratory Medicine Institute (RT-PLMI), Cleveland Clinic

Executive Director, West Cancer Center

Chief Data Scientist and Head of Computational Biology, Vir Biotechnology Inc.

Professor, Lewis Sigler Institute for Integrative Genomics, Princeton University

CEO and Managing Partner, New York Cancer & Blood Specialists

Vice Chair, SWOG GU Committee